Selank 11mg
Size: 11mg
$40.00
Current Batch Verification
- COA lot: ST01
- Document year: 2026
- This listing is linked only to the certificate for this finished batch. HPLC purity, when shown, is not a milligram assay of the vial.
In stock
Note: Shipped in freeze-dried lyophilized form — requires reconstitution before laboratory use.
Research Overview
Selank is a synthetic heptapeptide research analog supplied as a lyophilized powder for molecular characterization and analytical peptide studies.
Product Specifications
- Amount: 11mg
- Form: Lyophilized powder
- Molecular Formula: C33H57N11O9
- Molecular Weight: 751.9 g/mol
- Classification: Synthetic heptapeptide analog
Analytical Testing
- Lot: ST01
- Document year: 2026
- Method: See current Certificate of Analysis
Laboratory Storage and Handling
Store lyophilized vials sealed, protected from moisture, heat, and light. Typical laboratory practice is frozen storage until reconstitution. After reconstitution, follow your institutional protocol and avoid repeated freeze–thaw cycles.
Research-Use Statement
For laboratory research only. Not for human use. Not for diagnostic or therapeutic applications. Not for veterinary use. Statements on this page have not been evaluated by the FDA.
| Size | 11MG |
|---|---|
| SKU | revpep-selank-11mg |
| Category | Vials |
| Availability | In stock |
| Form | Lyophilized powder |
| Molecular Formula | C33H57N11O9 |
| Molecular Weight | 751.9 g/mol |
| Classification | Synthetic heptapeptide analog |
| Intended Use | Laboratory research only |
For laboratory research only. Products are supplied for analytical testing, method development, and peptide characterization — not for human or animal consumption, and not for diagnostic or therapeutic use.
- Handle and store according to your qualified laboratory protocols
- Verify identity and purity using your in-house analytical methods
- Dispose of materials in compliance with institutional guidelines
Statements on this site have not been evaluated by the FDA.
Reviews
There are no reviews yet.